{"id":2708,"date":"2025-04-08T06:10:04","date_gmt":"2025-04-08T06:10:04","guid":{"rendered":"https:\/\/visionranking.com\/wegovita\/?page_id=2708"},"modified":"2025-04-15T09:14:37","modified_gmt":"2025-04-15T09:14:37","slug":"treatment-plan-for-stage-i-liver-cancer-proton-beam-therapy-pbt-approach","status":"publish","type":"page","link":"https:\/\/visionranking.com\/wegovita\/treatment-plan-for-stage-i-liver-cancer-proton-beam-therapy-pbt-approach\/","title":{"rendered":"Treatment Plan for Stage I Liver Cancer \u2013 Proton Beam Therapy (PBT) Approach"},"content":{"rendered":"\t\t
\n\t\t\t\t\r\n
\n\t\t
\n\t\t\r\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t
All Treatments Services<\/a><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Contact Us<\/a><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

1. Initial Consulltation & Evaluation<\/h4>
  • Comprehensive assessment by:<\/li>
  • Radiation oncologist<\/li>
  • Hepatobiliiary surgeon<\/li>
  • Medical oncologist<\/li>
  • Evaluation of tumor size, location, and liver function to determine eligibility for curative-intent proton beam therapy.<\/li>
  • Discussion of treatment options, expected outcomes, and potential side effects.<\/li><\/ul>

    2. Medical Records Review & Pre-Treatment Assessment<\/h4>
    • Review of prior imaging, pathology reports, and medical history.<\/li>
    • Assessment of liver function using Child-Pugh score and ALBI score.<\/li>
    • Determination of performance status (ECOG\/KPS) to assess patient fitness for treatment.<\/li><\/ul>

      3. Laboratory Investigations<\/h4>
      • Complete blood count (CBC)<\/li>
      • liiver function tests (LFTs)<\/li>
      • Renal function panel<\/li>
      • Coagullation profile<\/li>
      • Tumor markers (Alpha-Fetoprotein \u2013 AFP)<\/li>
      • Hepatitis B and C serology (if applicable)<\/li><\/ul>

        4. Pre-Treatment Imaging<\/h4>
        • Multiphasic contrast-enhanced CT or MRI of the liver to define tumor margins and assess local involvement.<\/li>
        • PET-CT (if indicated) to rulle out extrahepatic disease.<\/li>
        • Simulation CT scan (4D-CT) for proton therapy planning, accounting for respiratory motion.<\/li><\/ul>

          5. Multidisciplinary Tumor Board Discussion<\/h4>
          • Case evaluation by a team including radiation oncologists, hepatobiliary surgeons, and interventional radiologists.<\/li>
          • Decision on treatment strategy:<\/li>
          • Definitive proton therapy as an alternative to surgery for inoperable patients.<\/li>
          • Adjuvant proton therapy if small residual tumor remains after resection.<\/li><\/ul>

            6. Treatment Planning & Preparation<\/h4>
            • Patient positioning and immobilization with a customized mold to minimize movement.<\/li>
            • Respiratory motion management, including breath-hold technique or respiratory gating.<\/li>
            • Proton therapy dose planning:<\/li>
            • Standard regimen: 67.5 Gy in 15 fractions (hypofractionated approach).<\/li>
            • Alternative regimen: 50\u201358 Gy in 5 fractions (for select cases with well-compensated liver function).<\/li>
            • Dosimetric evaluation to ensure high-dose delivery to the tumor while minimizing exposure to healthy liver tissue.<\/li><\/ul>

              7. Proton Therapy Sessions<\/h4>
              • Outpatient treatment schedule: Sessions administered 5 days per week for 3\u20134 weeks.<\/li>
              • Each session lasts 20\u201330 minutes, with proton delivery taking a few minutes.<\/li>
              • Pre-treatment imaging (CBCT or X-ray) before each session to verify positioning and tumor targeting.<\/li><\/ul>

                8. Management of Side Effects<\/h4>
                • Common side effects:<\/li>
                • Mild fatigue<\/li>
                • Nausea or mild GI discomfort<\/li>
                • Temporary elevation of liiver enzymes<\/li>
                • Rare but serious compliications:<\/li>
                • Radiation-induced liver disease (RILD) (monitored via LFTs).<\/li>
                • Regular follow-ups with supportive care as needed.<\/li><\/ul>

                  9. Post-Treatment Monitoring & Follow-Up<\/h4>
                  • First post-treatment imaging (CT\/MRI) at 1\u20132 months to assess tumor response.<\/li>
                  • AFP monitoring (if initially elevated) for recurrence detection.<\/li>
                  • Liver function tests every 4\u20136 weeks post-treatment to evaluate liver tolerance.<\/li>
                  • Long-term surveillance with imaging every 3\u20136 months to monitor for recurrence.<\/li><\/ul>

                    10. Next Steps & Additional Considerations<\/h4>
                    • Surgical reassessment if tumor downsizing is observed and patient becomes eligible for resection.<\/li>
                    • Systemic therapy consideration (e.g., immunotherapy or targeted therapy) if progression occurs.<\/li>
                    • Potential liver transplantation evaluation in selected cases.<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

                      All Treatments Services Contact Us 1. Initial Consulltation & Evaluation Comprehensive assessment by: Radiation oncologist Hepatobiliiary surgeon Medical oncologist Evaluation of tumor size, location, and liver function to determine eligibility for curative-intent proton beam therapy. Discussion of treatment options, expected outcomes, and potential side effects. 2. Medical Records Review & Pre-Treatment Assessment Review of prior…<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template-builder.php","meta":{"footnotes":""},"class_list":["post-2708","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/visionranking.com\/wegovita\/wp-json\/wp\/v2\/pages\/2708","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/visionranking.com\/wegovita\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/visionranking.com\/wegovita\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/visionranking.com\/wegovita\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/visionranking.com\/wegovita\/wp-json\/wp\/v2\/comments?post=2708"}],"version-history":[{"count":13,"href":"https:\/\/visionranking.com\/wegovita\/wp-json\/wp\/v2\/pages\/2708\/revisions"}],"predecessor-version":[{"id":3446,"href":"https:\/\/visionranking.com\/wegovita\/wp-json\/wp\/v2\/pages\/2708\/revisions\/3446"}],"wp:attachment":[{"href":"https:\/\/visionranking.com\/wegovita\/wp-json\/wp\/v2\/media?parent=2708"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}